P2

1. uji kolmogorov smirnov

Tests of Normality

Kolmogorov-Smirnova

Rute Statistic df Sig.

Onset Na-CMC ,260 2 .

Eritromisin ,260 2 .

Simetidin ,260 2 .

Rifampisin ,260 2 .

Propanolol ,260 2 .
Durasi Na-CMC ,260 2 .

Eritromisin ,260 2 .

Simetidin ,260 2 .
Rifampisin ,260 2 .

Propanolol ,260 2 .

a. Lilliefors Significance Correction

2. Uji Kruskal Wallis

Test Statisticsa,b

Onset Durasi

Chi-Square 6,218 6,873

df 4 4
Asymp. Sig. ,183 ,143

a. Kruskal Wallis Test

b. Grouping Variable: Rute
 P3

1. Uji kolmogorov smirnov

Tests of Normalityb

Kolmogorov-Smirnova Shapiro-Wilk

Subjek Statistic df Sig. Statistic df Sig.

Geliat Paracetamol ,175 3 . 1,000 3 1,000

Ibuprofen ,358 3 . ,813 3 ,145

Asam Mefenamat ,296 3 . ,918 3 ,444

Natrium Diklofenak ,251 3 . ,966 3 ,647

Na-CMC ,253 3 . ,964 3 ,637

Dayaanalgetik Paracetamol ,212 3 . ,990 3 ,811

Ibuprofen ,356 3 . ,816 3 ,154

Asam Mefenamat ,292 3 . ,923 3 ,464

Natrium Diklofenak ,247 3 . ,969 3 ,661

a. Lilliefors Significance Correction

b. Dayaanalgetik is constant when Subjek = Na-CMC. It has been omitted.

2. Uji kruskal wallis

Test Statisticsa,b

Geliat Dayaanalgetik

Chi-Square 7,388 7,102

df 4 4
Asymp. Sig. ,117 ,131

a. Kruskal Wallis Test

b. Grouping Variable: Subjek